As of 2024-12-14, the Relative Valuation of IGM Biosciences Inc (IGMS) is (99.46) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.17 USD, the upside of IGM Biosciences Inc based on Relative Valuation is -1487.1%.
The range of the Relative Valuation is (101.90) - (104.86) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.6x - 40.2x | 34.4x |
| Forward P/E multiples | 19.0x - 28.4x | 19.4x |
| Fair Price | (101.90) - (104.86) | (99.46) |
| Upside | -1521.2% - -1562.4% | -1487.1% |
| Date | P/E |
| 2024-12-09 | -2.75 |
| 2024-12-06 | -2.79 |
| 2024-12-05 | -2.56 |
| 2024-12-04 | -2.68 |
| 2024-12-03 | -2.85 |
| 2024-12-02 | -2.92 |
| 2024-11-29 | -2.72 |
| 2024-11-27 | -2.82 |
| 2024-11-26 | -2.56 |
| 2024-11-25 | -2.54 |
| 2024-11-22 | -2.40 |
| 2024-11-21 | -2.40 |
| 2024-11-20 | -2.64 |
| 2024-11-19 | -2.58 |
| 2024-11-18 | -2.49 |
| 2024-11-15 | -2.56 |
| 2024-11-14 | -2.73 |
| 2024-11-13 | -3.02 |
| 2024-11-12 | -3.07 |
| 2024-11-11 | -3.48 |
| 2024-11-08 | -3.52 |
| 2024-11-07 | -3.89 |
| 2024-11-06 | -3.94 |
| 2024-11-05 | -4.28 |
| 2024-11-04 | -4.24 |
| 2024-11-01 | -4.39 |
| 2024-10-31 | -4.64 |
| 2024-10-30 | -4.76 |
| 2024-10-29 | -4.67 |
| 2024-10-28 | -4.82 |
| 2024-10-25 | -4.55 |
| 2024-10-24 | -4.28 |
| 2024-10-23 | -4.34 |
| 2024-10-22 | -4.72 |
| 2024-10-21 | -4.24 |
| 2024-10-18 | -4.52 |
| 2024-10-17 | -4.34 |
| 2024-10-16 | -3.83 |
| 2024-10-15 | -4.17 |
| 2024-10-14 | -4.54 |
| 2024-10-11 | -4.06 |
| 2024-10-10 | -3.76 |
| 2024-10-09 | -3.68 |
| 2024-10-08 | -3.94 |
| 2024-10-07 | -3.71 |
| 2024-10-04 | -4.17 |
| 2024-10-03 | -4.03 |
| 2024-10-02 | -3.89 |
| 2024-10-01 | -3.92 |
| 2024-09-30 | -4.47 |